Geode Capital Management’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.88M Buy
2,390,147
+1,159,738
+94% +$2.12M ﹤0.01% 2934
2026
Q1
$2.2M Buy
1,230,409
+32,879
+3% +$69.8K ﹤0.01% 3083
2025
Q4
$2.68M Buy
1,197,530
+100,748
+9% +$265K ﹤0.01% 3057
2025
Q3
$2.66M Buy
1,096,782
+84,662
+8% +$225K ﹤0.01% 3088
2025
Q2
$600K Sell
1,012,120
-1,310,149
-56% -$1.02M ﹤0.01% 3492
2025
Q1
$2.04M Buy
2,322,269
+90,339
+4% +$125K ﹤0.01% 3022
2024
Q4
$3.77M Buy
2,231,930
+27,996
+1% +$50.5K ﹤0.01% 2873
2024
Q3
$4.23M Buy
2,203,934
+1,112,933
+102% +$2.53M ﹤0.01% 2847
2024
Q2
$2.68M Buy
1,091,001
+141,484
+15% +$380K ﹤0.01% 3031
2024
Q1
$1.56M Buy
949,517
+50,844
+6% +$74.7K ﹤0.01% 3210
2023
Q4
$1.6M Buy
898,673
+71,044
+9% +$152K ﹤0.01% 3179
2023
Q3
$3.79M Buy
827,629
+66,806
+9% +$639K ﹤0.01% 2780
2023
Q2
$8.51M Buy
760,823
+622,728
+451% +$6.63M ﹤0.01% 2381
2023
Q1
$1.56M Buy
138,095
+5,287
+4% +$56.3K ﹤0.01% 3135
2022
Q4
$911K Buy
132,808
+30,253
+29% +$289K ﹤0.01% 3385
2022
Q3
$924K Buy
+102,555
New +$892K ﹤0.01% 3427

Other funds holding PROK

Geode Capital Management's PROK Position: Q2 2026 in Review

Geode Capital Management increased its ProKidney (PROK) stake by 94% in Q2 2026, buying an estimated $2.12M and bringing the position to 2,390,147 shares worth $4.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

Geode Capital Management first reported a position in PROK in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.51M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Geode Capital Management held 2,390,147 shares of ProKidney worth $4.88M as of Q2 2026.
  • Geode Capital Management bought 1,159,738 ProKidney shares in Q2 2026, an estimated $2.12M.
  • ProKidney made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2934 holding.
  • Geode Capital Management first reported a position in ProKidney in Q3 2022 and has held it in 16 quarters since.
  • Geode Capital Management's ProKidney position peaked at $8.51M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.